Back to search

Article

The effects of Natalizumab Treatment on Astrocyte Metabolism in Multiple Sclerosis: A Longitudinal <sup>11</sup> C-acetate PET study

2026-06-01

Abstract excerpt

<h4>Objective: </h4> Astrocyte activation is increasingly recognized as an important component of multiple sclerosis (MS) pathology. Natalizumab (NTZ), a highly effective therapy for relapsing-remitting MS (RRMS), primarily blocks leukocyte trafficking into the central nervous system. However, its effects on astrocytic metabolism remain unclear. We investigated astrocyte-associated metabolic changes after NTZ trea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e9b81c61-7011-5039-b52d-e070b5ef1cce
DOI
10.64898/2026.05.22.26353552
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The effects of Natalizumab Treatment on Astrocyte Metabolism in Multiple Sclerosis: A Longitudinal <sup>11</sup> C-acetate PET studyDOI 10.64898/2026.05.22.26353552
Select a neighboring publication to make it the new centre.